Exploring the mechanisms of baicalin in diabetic cardiomyopathy: Insights from network pharmacology and experimental validation
Biomedical Reports · 23.06.2026 · 25 (2) · 1-11
DOI: 10.3892/br.2026.2170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Reports, online erschienen am 23.06.2026. Verfasst von Xuyong Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou People's Hospital, Wenzhou, Zhejiang…. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
. The present study offers insight into the key therapeutic mechanisms activated by baicalin, and its potential therapeutic targets, PTPN22 and TNF-α.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, The Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou People's Hospital, Wenzhou, Zhejiang 32500, P.R. China.
Zitieren
APA
Zhao, X., Xie, L., & Zhu, N. (2026). Exploring the mechanisms of baicalin in diabetic cardiomyopathy: Insights from network pharmacology and experimental validation. Biomedical Reports, 25(2), 1-11. https://doi.org/10.3892/br.2026.2170
Vancouver
Zhao X, Xie L, Zhu N. Exploring the mechanisms of baicalin in diabetic cardiomyopathy: Insights from network pharmacology and experimental validation. Biomedical Reports. 2026;25(2):1-11. doi:10.3892/br.2026.2170
BibTeX
@article{Zhao2026,
author = {Zhao, Xuyong and Xie, Lina and Zhu, Ning},
title = {Exploring the mechanisms of baicalin in diabetic cardiomyopathy: Insights from network pharmacology and experimental validation},
journal = {Biomedical Reports},
year = {2026},
volume = {25},
number = {2},
pages = {1--11},
doi = {10.3892/br.2026.2170}
}
EUVIMED